Product information and disease descriptionProduct descriptionProduct information
Indication
1 evidence topic · 1 source
FDA orphan-designated indication
| Field | Quoted record |
|---|---|
| Orphan designation | “Treatment of Primary Biliary Cholangitis (PBC)” |
Saroglitazar
Primary biliary cholangitis
- Manufacturer
- Zydus Therapeutics
- Regulatory submission
- NDA submitted by May 2026
- Last updated